ASX tech took a hit with global chaos while Opyl, Yojee, and RocketBoots made moves, but big Wall Street names are struggling with AI.

ASX kicks off strong but Trump’s tariff chaos and Star’s desperate search for cash have markets on edge, while MinRes faces ...

Chinese export controls have thrown the doors open for ASX tungsten players to supply the military metal to the West.

With $200 million of cash on hand, Clinuvel's financial position is the envy of other biotechs. But not everyone is happy.

Fintechs are using AI and alternative data to speed up loan approvals, making credit more accessible to those overlooked by traditional banks.

Morgans deputy head of research Adrian Prendergast says the east coast gas outlook makes Comet Ridge appealing to investors.

Investors are turning their attention to unique locations like Canada's Northwest Territories as governments back critical minerals.

RareX was the fastest growing ASX resources stock in March with a gallium find at Cummins Range, but gold stocks dominated.

Tesoro Gold (ASX:TSO) has identified a number of high-priority targets across its Chilean assets, hunting for gold.

Healthcare and medical manufacturing in Australia is gaining momentum with ASX companies at the forefront of growth.

A reported 3500 US Food & Drug Administration staff are headed for the guillotine, as part of Trump's broader purge of the health bureaucracy.